Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibition
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5594
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibition ; volume:41 ; number:40 ; day:6 ; month:9 ; year:2022 ; pages:4560-4572 ; date:9.2022
Oncogene ; 41, Heft 40 (6.9.2022), 4560-4572, 9.2022
- Creator
-
Winkler, René
Mägdefrau, Ann-Sophie
Piskor, Eva-Maria
Kleemann, Markus
Beyer, Mandy
Linke, Kevin
Hansen, Lisa
Schaffer, Anna-Maria
Hoffmann, Marina E.
Poepsel, Simon
Heyd, Florian
Beli, Petra
Möröy, Tarik
Mahboobi, Siavosh
Krämer, Oliver Holger
Kosan, Christian
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41388-022-02450-3
- URN
-
urn:nbn:de:101:1-2022121809062500072318
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Winkler, René
- Mägdefrau, Ann-Sophie
- Piskor, Eva-Maria
- Kleemann, Markus
- Beyer, Mandy
- Linke, Kevin
- Hansen, Lisa
- Schaffer, Anna-Maria
- Hoffmann, Marina E.
- Poepsel, Simon
- Heyd, Florian
- Beli, Petra
- Möröy, Tarik
- Mahboobi, Siavosh
- Krämer, Oliver Holger
- Kosan, Christian
- SpringerLink (Online service)
Other Objects (12)
Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma
Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL)
PICH deficiency limits the progression of MYC-induced B-cell lymphoma
Recalcitrant Subcutaneous Panniculitis-Like T-Cell Lymphoma Responsive to Histone Deacetylase Inhibitor
Histone deacetylase 6 in cancer
High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma
Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential
Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma
The effects of a histone deacetylase inhibitor on biological behavior of diffuse large B-cell lymphoma cell lines and insights into the underlying mechanisms
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Histone deacetylase 6 activity is critical for the metastasis of Burkitt’s lymphoma cells
B-cell receptor driven MALT1 activity regulates c-MYC signaling in mantle cell lymphoma
Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma
Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL)
PICH deficiency limits the progression of MYC-induced B-cell lymphoma
Recalcitrant Subcutaneous Panniculitis-Like T-Cell Lymphoma Responsive to Histone Deacetylase Inhibitor
Histone deacetylase 6 in cancer
High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma
Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential
Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma
The effects of a histone deacetylase inhibitor on biological behavior of diffuse large B-cell lymphoma cell lines and insights into the underlying mechanisms
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Histone deacetylase 6 activity is critical for the metastasis of Burkitt’s lymphoma cells
B-cell receptor driven MALT1 activity regulates c-MYC signaling in mantle cell lymphoma
Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma
Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL)
PICH deficiency limits the progression of MYC-induced B-cell lymphoma
Recalcitrant Subcutaneous Panniculitis-Like T-Cell Lymphoma Responsive to Histone Deacetylase Inhibitor
Histone deacetylase 6 in cancer
High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma
Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential
Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma
The effects of a histone deacetylase inhibitor on biological behavior of diffuse large B-cell lymphoma cell lines and insights into the underlying mechanisms
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Histone deacetylase 6 activity is critical for the metastasis of Burkitt’s lymphoma cells